Integrating Generative AI in Primary English Material Design: Insights from Indonesian Teachers’ Perceptions
Revija za elementarno izobraževanje · 18.03.2026 · 19 (1)
DOI: 10.18690/rei5409 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revija za elementarno izobraževanje, online erschienen am 18.03.2026. Verfasst von Tommy Hastomo und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study explored primary school teachers’ perceptions of Generative AI (GenAI) in English material design. Data from 20 certified Indonesian teachers were collected through interviews and document analysis. Findings indicate GenAI is valued for enhancing efficiency and personalization, especially in creating worksheets, reading texts, grammar tasks, and vocabulary lists. However, concerns emerged regarding pedagogical integration, ethical use, and lack of training. Teachers’ perceptions were shaped by their professional development experiences. The study underscores the urgent need for continuous, practice-based teacher training to develop AI literacy and ensure that GenAI supports, rather than replaces, instructional decision-making.
Zitieren
APA
Hastomo, T., Widiati, U., Ivone, F. M., & Zen, E. L. (2026). Integrating Generative AI in Primary English Material Design: Insights from Indonesian Teachers’ Perceptions. Revija za elementarno izobraževanje, 19(1). https://doi.org/10.18690/rei5409
Vancouver
Hastomo T, Widiati U, Ivone FM, Zen EL. Integrating Generative AI in Primary English Material Design: Insights from Indonesian Teachers’ Perceptions. Revija za elementarno izobraževanje. 2026;19(1). doi:10.18690/rei5409
BibTeX
@article{Hastomo2026,
author = {Hastomo, Tommy and Widiati, Utami and Ivone, Francisca Maria and Zen, Evynurul Laily},
title = {Integrating Generative AI in Primary English Material Design: Insights from Indonesian Teachers’ Perceptions},
journal = {Revija za elementarno izobraževanje},
year = {2026},
volume = {19},
number = {1},
doi = {10.18690/rei5409}
}
EUVIMED